Actelion to host an investor event at American College of Cardiology (ACC.15)
(Thomson Reuters ONE) -
Actelion Pharmaceuticals Ltd /
Actelion to host an investor event at American College of Cardiology (ACC.15)
. Processed and transmitted by NASDAQ OMX Corporate Solutions.
The issuer is solely responsible for the content of this announcement.
Dear member of the investment community
Following the presentation 'Effect of selexipag on morbidity/mortality in
pulmonary arterial hypertension: results of the GRIPHON study' by Vallerie V.
McLaughlin on March 15, 2015 at 12:00 p.m. PDT, Actelion will host an investor
event at American College of Cardiology (ACC.15).
This event is by invitation only for covering buy- and sell-side analysts as
well as institutional investors.
If you wish to attend, please contact: investor.relations(at)actelion.com
Meeting Information
15 March 2015
6.00 - 8.30 p.m. Pacific Daylight Time
Venue
Hard Rock Hotel
207 5th Avenue
San Diego, CA 92101
Highlights
Oral presentation entitled 'Effect of selexipag on morbidity/mortality in
pulmonary arterial hypertension: results of the GRIPHON study'.
Invitation PDF:
http://hugin.info/131801/R/1900510/675580.pdf
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Actelion Pharmaceuticals Ltd via GlobeNewswire
[HUG#1900510]
Unternehmensinformation / Kurzprofil:
Datum: 09.03.2015 - 17:35 Uhr
Sprache: Deutsch
News-ID 377100
Anzahl Zeichen: 1872
contact information:
Town:
Allschwil
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 156 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Actelion to host an investor event at American College of Cardiology (ACC.15)"
steht unter der journalistisch-redaktionellen Verantwortung von
Actelion Pharmaceuticals Ltd (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
